Mineralys Therapeutics
Mineralys Therapeutics is a publicly traded, clinical-stage biotechnology company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. Our initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that we are developing for cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease.
Mineralys is a fully remote company.
For more information, please visit https://mineralystx.com. Follow Mineralys on LinkedIn.
Is Mineralys Therapeutics hiring?
Yes — Mineralys Therapeutics has 118 open jobs on JobsRadar right now. 2 of them were opened in the last 30 days. 117 of them disclose pay, at a median of $147,500 a year. The board was last refreshed on September 17, 2026 at 21:08 UTC.
Frequently asked questions
- Is Mineralys Therapeutics hiring?
- Yes. Mineralys Therapeutics has 118 open jobs on JobsRadar as of September 17, 2026. 2 of them were opened in the last 30 days.
- What roles is Mineralys Therapeutics hiring for?
- Mineralys Therapeutics is hiring for roles in Commercial, Biostatistics, Clinical Development and Finance.
- What does Mineralys Therapeutics pay?
- Across the 117 Mineralys Therapeutics jobs that disclose pay, the median is $147,500 a year.
- How current are these listings?
- Every listing comes straight from the employer’s own careers system and is re-checked three times a day. This page was last updated on September 17, 2026 at 21:08 UTC.